RxDoctor Payments Data

Jason Hurd, MD

Vascular Surgery · Missoula, MTNPI 1093081150

Payments from drug & device makers

What this record shows

This record is dominated by grants: $5,000 of the $5,346 with a category attached, or 93.5%. Medtronic accounts for 93.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $5,010 and has fallen 98.8% since, to $60 in 2024.

$5,346in general payments, 2019–2025

Across 15 payments — averaging $356.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Cook Medical LLC$148
  • W. L. Gore & Associates, Inc.$141
  • Getinge USA Sales, LLC$35

What the payments were for

  • Grants$5,00094%
  • Food & beverage$3466%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)4$5,023
Cook Medical LLC4$148
W. L. Gore & Associates, Inc.5$141
Getinge USA Sales, LLC2$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular surgery providers in Montanato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$268,040
Medicare patients
520
Services billed
1,216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate25$187

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →